Ligand validation:3DAF

FEG: 5'-O-[(S)-{[2-(carboxymethyl)-6-hydroxy-3,5-dimethylpyridin-4-yl]oxy}(hydroxy)phosphoryl]guanosine

FEG is a Ligand Of Interest in 3DAF designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3DAF_FEG_A_501	58%	15%	0.119	0.896	1.43	2.32	4	17	9	2	100%	1
3DAG_FEG_A_501	64%	17%	0.108	0.906	1.38	2.17	4	17	5	2	100%	1
5OK4_FEG_A_404	97%	27%	0.056	0.973	1.57	1.4	5	7	1	0	100%	1
3WB0_FEG_A_201	71%	13%	0.099	0.918	2.36	1.65	7	9	0	0	100%	1
3WVC_FEG_B_201	64%	8%	0.142	0.941	2.76	1.98	15	9	8	0	100%	1
6YK9_FEG_A_401	62%	48%	0.119	0.924	0.9	1.11	2	2	3	0	92%	0.9189

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.